New CEO at Phytopharm
This article was originally published in Scrip
Executive Summary
Phytopharm (UK) has appointed Tim Sharpington chief executive officer and board director. Sandy Morrison, the company's interim CEO, will revert to his position as a non-executive director. Mr Sharpington has nearly 20 years' experience in the life sciences sector with various biotechnology and pharmaceutical service companies. In 2002, he was development director at Arakis, which was sold to Sosei in 2005 for £107 million. After leaving Arakis, he founded and became CEO of Serentis in 2006. Mr Sharpington is also a non-executive director of Clinical Force, a clinical trial software and service company.